TLR5 Signaling Causes Dendritic Cell Dysfunction and Orchestrates Failure of Immune Checkpoint Therapy against Ovarian Cancer.
Saved in:
| Title: | TLR5 Signaling Causes Dendritic Cell Dysfunction and Orchestrates Failure of Immune Checkpoint Therapy against Ovarian Cancer. |
|---|---|
| Authors: | McGinty MT; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia., Putelo AM; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia., Kolli SH; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia., Feng TY; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia., Dietl MR; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia., Hatzinger CN; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia., Bajgai S; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia., Poblete MK; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia., Azar FN; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia., Mohammad A; Bioinformatics Core, University of Virginia School of Medicine, Charlottesville, Virginia., Kumar P; Bioinformatics Core, University of Virginia School of Medicine, Charlottesville, Virginia.; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia., Rutkowski MR; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia. |
| Source: | Cancer immunology research [Cancer Immunol Res] 2025 May 02; Vol. 13 (5), pp. 696-711. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
